Life Pharms Inc.

UEI
LJ5JU6A99KW7
CAGE
4AZG7
Primary NAICS
561499 All Other Business Support Services
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Limited Liability Company
  • Hispanic American Owned
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
The development of a novel antifungal for drug resistance R43AI188858 National Institute of Allergy and Infectious Diseases (NIH) $300,000
Antifungal therapy against drug resistant fungal pathogens. R44AI098708 National Institute of Allergy and Infectious Diseases (NIH) $1,518,052
HSP90 inhibitors to combat antifungal drug resistance. R43AI098708 National Institutes of Health $299,998
Novel antifungals for immunocompromised/HIV patients. R43AI093281 National Institutes of Health $300,000
Novel antibacterial scaffold from natural products R43AI096847 National Institutes of Health $587,757

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Life Pharms Inc. registered in SAM.gov?

Life Pharms Inc.'s SAM.gov registration expired on December 3, 2025.

What is Life Pharms Inc.'s most recent federal award?

Life Pharms Inc.'s most recent federal grant award is The development of a novel antifungal for drug resistance (R43AI188858), from National Institute of Allergy and Infectious Diseases (NIH), on September 19, 2025.

On GovTribe

See Life Pharms Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login